Eledon Pharmaceuticals, Inc. — Balance Sheet Charts
15 snapshots of history · ending 2017-03-31 · SEC EDGAR
Source:10-K · 10-Q
Assets vs Liabilities
Cash Position Breakdown
Working Capital Components
Capital Structure (LT Debt / Cash / Equity)
Total Assets↓-55.2% -$32M
$26M
Current Assets↓-55.0% -$31M
$26M
Cash & Equivalents↑+70.6% +$10M
$24M
ST Investments
—
Net PPE↓-82.3% -$373K
$80K
Goodwill
—
Total Liabilities↓-60.9% -$4M
$2M
Current Liabilities↓-60.8% -$4M
$2M
Account Payables↓-85.4% -$2M
$276K
Stockholders Equity↓-54.6% -$28M
$23M
Retained Earnings↓-21.3% -$30M
$-173M
Operating Lease ROU Asset
—
Operating Lease Liability
—
Gross PP&E↓-65.1% -$426K
$228K
Accumulated Depreciation↓-21.2% -$35K
$130K